Please Wait
Applying Filters...
Menu
Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 5Fragmin

PharmaCompass

01

Brand Name : Fragmin

Dalteparin

arrow
IFT FIRST
Not Confirmed

Brand Name : Fragmin

arrow
IFT FIRST
Not Confirmed

Dalteparin

Main Therapeutic Indication : Anticoagulants

Currency : USD

2014 Revenue in Millions : 1.40%

2013 Revenue in Millions :

Growth (%) :

blank

02

Brand Name : Fragmin

Dalteparin

arrow
IFT FIRST
Not Confirmed

Brand Name : Fragmin

arrow
IFT FIRST
Not Confirmed

Dalteparin

Main Therapeutic Indication : Anticoagulants

Currency : USD

2015 Revenue in Millions : 364

2014 Revenue in Millions : 335

Growth (%) : -8%

blank

03

Brand Name : Fragmin

Dalteparin

arrow
IFT FIRST
Not Confirmed

Brand Name : Fragmin

arrow
IFT FIRST
Not Confirmed

Dalteparin

Main Therapeutic Indication : Blood Disorders

Currency : USD

2016 Revenue in Millions : 318

2015 Revenue in Millions : 335

Growth (%) : -5

blank

04

Brand Name : Fragmin

Dalteparin

arrow
IFT FIRST
Not Confirmed

Brand Name : Fragmin

arrow
IFT FIRST
Not Confirmed

Dalteparin

Main Therapeutic Indication : Blood Disorders

Currency : USD

2017 Revenue in Millions : 306

2016 Revenue in Millions : 318

Growth (%) : -4

blank

05

Brand Name : Fragmin

Dalteparin

arrow
IFT FIRST
Not Confirmed

Brand Name : Fragmin

arrow
IFT FIRST
Not Confirmed

Dalteparin

Main Therapeutic Indication : Blood Disorders

Currency : USD

2018 Revenue in Millions : 293

2017 Revenue in Millions : 306

Growth (%) : -4%

blank